Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Jan-24 8:40 PM View:  | Rain Oncology Inc. (RAIN) | 25-Jan-24 | Disposition (change in control) | 8,576,800 | -- | -- | (100%) 8.58M to 0 | |
| 20-Dec-23 6:09 PM View: | Point Biopharma Global Inc. (RACA) | 18-Dec-23 | Private Sale | 17,161,300 | $12.45 | $213,658,000.00 | (100%) 17.16M to 0 | |
| 17-Nov-23 4:54 PM View: | Repare Therapeutics Inc. (RPTX) | 16-Nov-23 | Purchase | 295,745 | $5.38 | $1,592,200.00 | 3% 9.87M to 10.17M | |
| 17-Nov-23 4:54 PM View: | Repare Therapeutics Inc. (RPTX) | 15-Nov-23 | Private Purchase | 931,556 | $5.00 | $4,657,690.00 | 10% 8.94M to 9.87M | |
| 06-Nov-23 6:07 PM View: | Kymera Therapeutics, Inc. (KYMR) | 03-Nov-23 | Purchase | 197,699 | $14.07 | $2,781,410.00 | 4% 4.86M to 5.05M | |
| 06-Nov-23 6:07 PM View: | Kymera Therapeutics, Inc. (KYMR) | 02-Nov-23 | Private Purchase | 216,406 | $11.64 | $2,519,920.00 | 5% 4.64M to 4.86M | |
| 03-Nov-23 5:37 PM View: | Repare Therapeutics Inc. (RPTX) | 02-Nov-23 | Private Purchase | 783,709 | $3.60 | $2,821,350.00 | 10% 8.16M to 8.94M | |
| 14-Sep-23 4:25 PM View: | Olema Pharmaceuticals, Inc. (OLMA) | 14-Sep-23 | Acquisition (other) | 99,556 | -- | -- | 1% 8.8M to 8.9M | |
| 14-Sep-23 4:25 PM View: | Olema Pharmaceuticals, Inc. (OLMA) | 12-Sep-23 | Purchase | 1,505,930 | $9.84 | $14,818,400.00 | 21% 7.29M to 8.8M | |
| 28-Jun-23 6:26 PM View: | Cell Therapeutics, Inc. (CTIC) | 26-Jun-23 | Disposition (change in control) | 7,286,870 | $9.10 | $66,310,600.00 | (82%) 8.86M to 1.57M | |
| 28-Jun-23 6:26 PM View: | Cell Therapeutics, Inc. (CTIC) | 26-Jun-23 | Disposition (change in control) | 1,569,290 | $9.10 | $14,280,500.00 | (100%) 1.57M to 0 | |
| 12-May-23 8:00 PM View: | Structure Therapeutics Inc. (GPCR) | 10-May-23 | Disposition (other) | 7,410,520 | -- | -- | (59%) 12.58M to 5.17M | |
| 09-May-23 8:25 PM View: | Eledon Pharmaceuticals, Inc. (NVUS) | 05-May-23 | Purchase | 1,978,930 | -- | -- | 86% 2.31M to 4.29M | |
| 19-Jan-23 6:30 PM View: | Cullinan Oncology, Inc. (CGEM) | 19-Jan-23 | Disposition (other) | 6,400,000 | -- | -- | (86%) 7.42M to 1.02M | |
| 13-Jan-23 5:08 PM View: | Kymera Therapeutics, Inc. (KYMR) | 12-Jan-23 | Purchase | 18,897 | $31.24 | $590,391.00 | < 1% 4.62M to 4.64M | |
| 13-Jan-23 5:08 PM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Jan-23 | Private Purchase | 22,110 | $29.89 | $660,799.00 | < 1% 4.6M to 4.62M | |
| 09-Jan-23 5:44 PM View: | XOMA Ltd. (XOMA) | 06-Jan-23 | Purchase | 3,249 | $21.98 | $71,418.50 | < 1% 3.84M to 3.85M | |
| 09-Jan-23 5:44 PM View: | XOMA Ltd. (XOMA) | 05-Jan-23 | Private Purchase | 19,000 | $18.39 | $349,319.00 | < 1% 3.82M to 3.84M | |
| 22-Dec-22 6:49 PM View: | Third Harmonic Bio, Inc. (THRD) | 20-Dec-22 | Private Purchase | 214,063 | $4.11 | $879,499.00 | 5% 4.12M to 4.34M | |
| 10-Nov-22 6:31 PM View: | Rain Oncology Inc. (RAIN) | 08-Nov-22 | Private Purchase | 1,710,360 | $5.83 | $9,971,390.00 | 25% 6.87M to 8.58M | |
| 27-Sep-22 7:22 PM View: | XOMA Ltd. (XOMA) | 27-Sep-22 | Purchase | 1,682 | $16.89 | $28,409.30 | < 1% 3.82M to 3.82M | |
| 27-Sep-22 7:22 PM View: | XOMA Ltd. (XOMA) | 26-Sep-22 | Purchase | 6,360 | $16.83 | $107,050.00 | < 1% 3.82M to 3.82M | |
| 27-Sep-22 7:22 PM View: | XOMA Ltd. (XOMA) | 23-Sep-22 | Private Purchase | 16,600 | $16.50 | $273,850.00 | < 1% 3.8M to 3.82M | |
| 16-Sep-22 6:30 PM View: | XOMA Ltd. (XOMA) | 16-Sep-22 | Purchase | 24,293 | $17.89 | $434,536.00 | < 1% 3.77M to 3.8M | |
| 16-Sep-22 6:30 PM View: | XOMA Ltd. (XOMA) | 15-Sep-22 | Purchase | 5,575 | $17.96 | $100,138.00 | < 1% 3.77M to 3.77M | |
| 16-Sep-22 6:30 PM View: | XOMA Ltd. (XOMA) | 14-Sep-22 | Private Purchase | 26,441 | $17.25 | $456,044.00 | < 1% 3.74M to 3.77M | |
| 23-Aug-22 5:35 PM View: | Kymera Therapeutics, Inc. (KYMR) | 22-Aug-22 | Private Purchase | 545,525 | $26.00 | $14,183,600.00 | 13% 4.05M to 4.6M | |
| 11-Aug-22 5:52 PM View: | Cell Therapeutics, Inc. (CTIC) | 09-Aug-22 | Conversion | 6,863,330 | -- | -- | 76% 8.97M to 15.84M | |
| 11-Aug-22 5:52 PM View: | Cell Therapeutics, Inc. (CTIC) | 09-Aug-22 | Conversion | 1,520,000 | -- | -- | 10% 15.84M to 17.36M | |
| 11-Aug-22 5:52 PM View: | Cell Therapeutics, Inc. (CTIC) | 09-Aug-22 | Sale | 7,210,570 | $6.12 | $44,128,700.00 | (42%) 17.36M to 10.15M | |
| 11-Aug-22 5:52 PM View: | Cell Therapeutics, Inc. (CTIC) | 09-Aug-22 | Sale | 1,289,430 | $6.12 | $7,891,340.00 | (13%) 10.15M to 8.86M | |
| 15-Jun-22 6:15 PM View: | Repare Therapeutics Inc. (RPTX) | 13-Jun-22 | Private Purchase | 149,161 | $12.73 | $1,898,820.00 | 2% 8.01M to 8.16M | |
| 14-Jun-22 4:46 PM View: | Olema Pharmaceuticals, Inc. (OLMA) | 10-Jun-22 | Private Purchase | 200,000 | $4.03 | $806,900.00 | 3% 7.09M to 7.29M | |
| 06-Jun-22 6:14 PM View: | Repare Therapeutics Inc. (RPTX) | 06-Jun-22 | Purchase | 6,869 | $13.21 | $90,751.90 | < 1% 8.0M to 8.01M | |
| 06-Jun-22 6:14 PM View: | Repare Therapeutics Inc. (RPTX) | 03-Jun-22 | Purchase | 644,044 | $12.29 | $7,912,720.00 | 9% 7.36M to 8.0M | |
| 06-Jun-22 6:14 PM View: | Repare Therapeutics Inc. (RPTX) | 02-Jun-22 | Private Purchase | 1,186,040 | $11.68 | $13,855,900.00 | 19% 6.17M to 7.36M | |
| 03-Jun-22 6:24 PM View: | Cullinan Oncology, Inc. (CGEM) | 01-Jun-22 | Private Purchase | 751,396 | $11.00 | $8,264,910.00 | 11% 6.66M to 7.42M | |
| 31-May-22 7:50 PM View: | Kymera Therapeutics, Inc. (KYMR) | 27-May-22 | Purchase | 65,369 | $14.78 | $966,337.00 | 2% 3.99M to 4.05M | |
| 31-May-22 7:50 PM View: | Kymera Therapeutics, Inc. (KYMR) | 26-May-22 | Private Purchase | 224,057 | $14.21 | $3,183,980.00 | 6% 3.76M to 3.99M | |
| 24-May-22 8:09 PM View: | Kymera Therapeutics, Inc. (KYMR) | 20-May-22 | Private Purchase | 10,100 | $14.00 | $141,394.00 | < 1% 3.75M to 3.76M | |
| 20-May-22 6:09 PM View: | Repare Therapeutics Inc. (RPTX) | 18-May-22 | Private Purchase | 420,000 | $8.50 | $3,570,000.00 | 7% 5.75M to 6.17M | |
| 16-May-22 7:34 PM View: | Cullinan Oncology, Inc. (CGEM) | 13-May-22 | Purchase | 109,900 | $9.14 | $1,003,940.00 | 2% 6.55M to 6.66M | |
| 16-May-22 7:34 PM View: | Cullinan Oncology, Inc. (CGEM) | 12-May-22 | Private Purchase | 1,000,000 | $9.06 | $9,060,000.00 | 18% 5.55M to 6.55M | |
| 09-May-22 7:20 PM View: | Kymera Therapeutics, Inc. (KYMR) | 06-May-22 | Purchase | 100,000 | $19.25 | $1,925,500.00 | 3% 3.65M to 3.75M | |
| 09-May-22 7:20 PM View: | Kymera Therapeutics, Inc. (KYMR) | 05-May-22 | Private Purchase | 150,000 | $19.60 | $2,939,860.00 | 4% 3.5M to 3.65M | |
| 05-Apr-22 6:45 PM View: | Cullinan Oncology, Inc. (CGEM) | 01-Apr-22 | Private Purchase | 276,000 | $10.75 | $2,966,970.00 | 5% 5.28M to 5.55M | |
| 31-Jan-22 7:44 PM View: | Kymera Therapeutics, Inc. (KYMR) | 31-Jan-22 | Purchase | 34,408 | $40.70 | $1,400,410.00 | < 1% 3.47M to 3.5M | |
| 31-Jan-22 7:44 PM View: | Kymera Therapeutics, Inc. (KYMR) | 27-Jan-22 | Private Purchase | 95,901 | $38.33 | $3,676,070.00 | 3% 3.37M to 3.47M | |
| 26-Jan-22 7:43 PM View: | Kymera Therapeutics, Inc. (KYMR) | 24-Jan-22 | Private Purchase | 272,767 | $37.76 | $10,300,600.00 | 9% 3.1M to 3.37M | |
| 21-Jan-22 5:12 PM View: | Repare Therapeutics Inc. (RPTX) | 19-Jan-22 | Private Purchase | 997,961 | $14.10 | $14,071,200.00 | 21% 4.75M to 5.75M |